MedTrace Logo

A Long Term Prospective Follow Up Study For The CATO Study (SAS30018/SER9702)

NCT00441675 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 137

Last updated 2012-03-19

No results posted yet for this study

Summary

The CATO population is a very well documented population during two years. During this study patients were treated according to the CATO algorithm, after that patient were treated according to the Dutch national (GINA derived) guidelines up to 6 years of follow-up. The purpose of this prospective follow-up study is to understand the long-term effects of treatment. Therefore the measurements done at baseline (CATO part 1) are repeated after 6 years in this CATO-population (CATO follow-up).

Conditions

Interventions

PROCEDURE

Symptom Score

Symptom Score

PROCEDURE

Symptom Score and PD20

Symptom Score and PD20

Sponsors & Collaborators

Principal Investigators

  • GSK Clinical Trials · GlaxoSmithKline

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-01-31
Primary Completion
2007-10-31
Completion
2007-10-31

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00441675 on ClinicalTrials.gov